No products in the cart.
Swedish study reports low vision loss risk with GLP-1RAs
1. In this cohort study, glucagon-like peptide-1 receptor agonist (GLP-1RA) use was associated with a higher risk of anterior ischemic...
Endocrinology
Reports of high-impact endocrinology studies by medical professionals
GLP-1RAs may increase ischemic optic neuropathy risk
1. In this target trial emulation, glucagon-like peptide-1 receptor agonist (GLP-1RA) use was associated with a small increase in the...
GLP-1RAs showed no advantage for basal insulin discontinuation
1. In this target trial emulation, initiating a glucagon-like peptide-1 receptor agonist (GLP-1RA) was not associated with higher rates of...
Sleep restriction promotes weight gain in high-risk adults
1. In this pooled analysis of randomized crossover trials, chronic mild sleep restriction was associated with modest increases in body...
Resistance training is associated with lower risk of type 2 diabetes
1. Resistance training among US adult health care professionals was associated with lower type 2 diabetes (T2D) risk, especially when...
Biweekly glucagon-like peptide-1 receptor agonist bofanglutide improves glycemic control
1. In this randomized controlled trial, biweekly injections of the novel glucagon-like peptide-1 receptor agonist (GLP-1RA) bofanglutide resulted in greater...
Telehealth yields modest improvements in diabetes outcomes
1. In this randomized trial, a comprehensive telehealth program produced modest but non-significant improvements in glycemic control compared with self-monitoring...
High intake of sugar-sweetened beverages is associated with increased risk of hepatocellular carcinoma
1. Increased intake of sugar-sweetened beverages was associated with increased risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma, while intake of...
Food coloring additives are associated with higher incidence of type 2 diabetes
1. Several widely consumed natural and synthetic food coloring additives were associated with higher type 2 diabetes incidence. Evidence Rating...
Statin use after but not before breast cancer diagnosis is associated with improved mortality in hormone receptor-positive early breast cancer
1. Prediagnostic statin use was not associated with higher survival among patients with early breast cancer. 2. Postdiagnostic statin use...
